Ignyte Acquisition
Why Robinhood?
You can watch IGNY and buy or sell other stocks, ETFs, and their options commission-free!About IGNY
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.
IGNY Key Statistics
Stock Snapshot
With a market cap of 520.3K, Ignyte Acquisition(IGNY) trades at $0.02. The stock has a price-to-earnings ratio of -0.14.
On 2026-03-02, Ignyte Acquisition(IGNY) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Ignyte Acquisition(IGNY) stock has reached 0, versus its average volume of 6.61K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.26.
The stock's 52-week range extends from a low of $0.00 to a high of $0.26.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.